Sino BiologicalInc Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Sino BiologicalInc is forecast to grow earnings and revenue by 24.9% and 15.6% per annum respectively. EPS is expected to grow by 25.5% per annum. Return on equity is forecast to be 3.9% in 3 years.

Anahtar bilgiler

24.9%

Kazanç büyüme oranı

25.5%

EPS büyüme oranı

Biotechs kazanç büyümesi44.8%
Gelir büyüme oranı15.6%
Gelecekteki özkaynak getirisi3.9%
Analist kapsamı

Low

Son güncelleme19 Sep 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Sino Biological,Inc.'s (SZSE:301047) Shares Climb 31% But Its Business Is Yet to Catch Up

Sep 30
Sino Biological,Inc.'s (SZSE:301047) Shares Climb 31% But Its Business Is Yet to Catch Up

Sino BiologicalInc (SZSE:301047) Is Paying Out A Dividend Of CN¥2.00

May 21
Sino BiologicalInc (SZSE:301047) Is Paying Out A Dividend Of CN¥2.00

Sino Biological,Inc.'s (SZSE:301047) P/E Is Still On The Mark Following 26% Share Price Bounce

May 08
Sino Biological,Inc.'s (SZSE:301047) P/E Is Still On The Mark Following 26% Share Price Bounce

Beyond Lackluster Earnings: Potential Concerns For Sino BiologicalInc's (SZSE:301047) Shareholders

May 06
Beyond Lackluster Earnings: Potential Concerns For Sino BiologicalInc's (SZSE:301047) Shareholders

Kazanç ve Gelir Büyüme Tahminleri

SZSE:301047 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/2026878264N/A2861
12/31/2025736208N/A2001
12/31/2024626162N/A1471
9/30/2024635154165221N/A
6/30/2024660195180233N/A
3/31/2024642220-562306N/A
12/31/2023646260-721323N/A
9/30/2023620232-826256N/A
6/30/2023568246-840263N/A
3/31/2023556272-112214N/A
1/1/202357530393249N/A
9/30/2022583440223357N/A
6/30/2022630470271368N/A
3/31/2022685502411470N/A
1/1/2022965720595643N/A
9/30/20211,3419339811,009N/A
6/30/20211,7361,2361,3171,338N/A
3/31/20211,9421,3961,2931,313N/A
12/31/20201,5961,1281,0751,093N/A
12/31/201918136842N/A
12/31/2018139361037N/A
12/31/201710113N/A23N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 301047's forecast earnings growth (24.9% per year) is above the savings rate (2.9%).

Kazançlar ve Piyasa: 301047's earnings (24.9% per year) are forecast to grow slower than the CN market (25.8% per year).

Yüksek Büyüme Kazançları: 301047's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: 301047's revenue (15.6% per year) is forecast to grow faster than the CN market (14% per year).

Yüksek Büyüme Geliri: 301047's revenue (15.6% per year) is forecast to grow slower than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 301047's Return on Equity is forecast to be low in 3 years time (3.9%).


Büyüyen şirketleri keşfedin